168 related articles for article (PubMed ID: 26160608)
21. Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder?
Onder E; Tural U; Gökbakan M
Eur Arch Psychiatry Clin Neurosci; 2008 Sep; 258(6):319-23. PubMed ID: 18297416
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy of nonhormonal drugs on menopausal hot flashes.
Li L; Xu L; Wu J; Dong L; Zhao S; Zheng Q
Eur J Clin Pharmacol; 2016 Sep; 72(9):1051-8. PubMed ID: 27450233
[TBL] [Abstract][Full Text] [Related]
23. Clinical update: new treatments for hot flushes.
Stearns V
Lancet; 2007 Jun; 369(9579):2062-4. PubMed ID: 17586289
[No Abstract] [Full Text] [Related]
24. EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms.
Mintziori G; Lambrinoudaki I; Goulis DG; Ceausu I; Depypere H; Erel CT; Pérez-López FR; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M
Maturitas; 2015 Jul; 81(3):410-3. PubMed ID: 25982505
[TBL] [Abstract][Full Text] [Related]
25. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.
Loprinzi CL; Kugler JW; Barton DL; Dueck AC; Tschetter LK; Nelimark RA; Balcueva EP; Burger KN; Novotny PJ; Carlson MD; Duane SF; Corso SW; Johnson DB; Jaslowski AJ
J Clin Oncol; 2007 Jan; 25(3):308-12. PubMed ID: 17146104
[TBL] [Abstract][Full Text] [Related]
26. Hot flashes in palliative care. Part 2 #262.
Lefkowits CC; Arnold RM
J Palliat Med; 2013 Jan; 16(1):101-2. PubMed ID: 23317326
[No Abstract] [Full Text] [Related]
27. Clinical inquiries. What nonhormonal therapies are effective for postmenopausal vasomotor symptoms?
Brewer D; Nashelsky J; Hansen LB
J Fam Pract; 2003 Apr; 52(4):324-5, 329. PubMed ID: 12681094
[No Abstract] [Full Text] [Related]
28. Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause.
Pinkerton JV; Kagan R; Portman D; Sathyanarayana R; Sweeney M;
Menopause; 2014 Jun; 21(6):567-73. PubMed ID: 24149930
[TBL] [Abstract][Full Text] [Related]
29. Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial.
Garland SN; Xie SX; Li Q; Seluzicki C; Basal C; Mao JJ
Menopause; 2017 May; 24(5):517-523. PubMed ID: 27875389
[TBL] [Abstract][Full Text] [Related]
30. Gabapentin Treatment in Bruxism Associated With Fluoxetine.
Soyata AZ; Oflaz S
J Clin Psychopharmacol; 2015 Aug; 35(4):481-3. PubMed ID: 26039015
[No Abstract] [Full Text] [Related]
31. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
Cobin RH; Goodman NF;
Endocr Pract; 2017 Jul; 23(7):869-880. PubMed ID: 28703650
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.
Shan D; Zou L; Liu X; Shen Y; Cai Y; Zhang J
Am J Obstet Gynecol; 2020 Jun; 222(6):564-579.e12. PubMed ID: 31870736
[TBL] [Abstract][Full Text] [Related]
33. Use of gabapentin in patients experiencing hot flashes.
Brown JN; Wright BR
Pharmacotherapy; 2009 Jan; 29(1):74-81. PubMed ID: 19113798
[TBL] [Abstract][Full Text] [Related]
34. Hot flashes refractory to HRT and SSRI therapy but responsive to gabapentin therapy.
Guttuso T
J Pain Symptom Manage; 2004 Mar; 27(3):274-6. PubMed ID: 15038336
[TBL] [Abstract][Full Text] [Related]
35. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.
Moraska AR; Atherton PJ; Szydlo DW; Barton DL; Stella PJ; Rowland KM; Schaefer PL; Krook J; Bearden JD; Loprinzi CL
J Support Oncol; 2010; 8(3):128-32. PubMed ID: 20552926
[TBL] [Abstract][Full Text] [Related]
36. Treatment of hot flushes in breast and prostate cancer.
Adelson KB; Loprinzi CL; Hershman DL
Expert Opin Pharmacother; 2005 Jun; 6(7):1095-106. PubMed ID: 15957964
[TBL] [Abstract][Full Text] [Related]
37. Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.
Joffe H; Guthrie KA; Larson J; Cohen LS; Carpenter JS; Lacroix AZ; Freeman EW
Menopause; 2013 Mar; 20(3):261-8. PubMed ID: 23435022
[TBL] [Abstract][Full Text] [Related]
38. The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.
Hickey M; Emery LI; Gregson J; Doherty DA; Saunders CM
Menopause; 2010 Jul; 17(4):727-33. PubMed ID: 20512079
[TBL] [Abstract][Full Text] [Related]
39. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E.
Biglia N; Sgandurra P; Peano E; Marenco D; Moggio G; Bounous V; Tomasi Cont N; Ponzone R; Sismondi P
Climacteric; 2009 Aug; 12(4):310-8. PubMed ID: 19415540
[TBL] [Abstract][Full Text] [Related]
40. Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial.
Oktem M; Eroglu D; Karahan HB; Taskintuna N; Kuscu E; Zeyneloglu HB
Adv Ther; 2007; 24(2):448-61. PubMed ID: 17565936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
